Monday, 9 March 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 09 March 2026
News

11 new drugs hit the TGA's desk

Posted 9 March 2026 AM

Eleven companies hoping to launch novel drugs in Australia are currently awaiting the TGA’s outcome after their applications were accepted for review between November and January.

There are some big names on the list, including Eli Lilly’s once-daily oral GLP-1 drug orforglipron, submitted for both type 2 diabetes patients and to support weight loss and long-term weight management.

To see the whole article, please login

Popular

Best pharmas for women
Hardest jobs to fill in pharma
Fresh PBAC agenda drops
New jobs: Who's gone where?
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home